1,035
Views
7
CrossRef citations to date
0
Altmetric
Meeting Report

Update on melanoma and non-melanoma skin cancer

, , , , , & show all
Pages 1829-1832 | Published online: 10 Jan 2014

References

  • Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J. Natl Cancer Inst.95(11), 806–812 (2003).
  • Whiteman DC, Pavan WJ, Bastian BC. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Pigment Cell Melanoma Res.24(5), 879–897 (2011).
  • Zalaudek I, Catricalà C, Moscarella E, Argenziano G. What dermoscopy tells us about nevogenesis. J. Dermatol.38(1), 16–24 (2011).
  • Zalaudek I, Guelly C, Pellacani G et al. The dermoscopical and histopathological patterns of nevi correlate with the frequency of BRAF mutations. J. Invest. Dermatol.131(2), 542–545 (2011).
  • Welch HG, Black WC. Overdiagnosis in cancer. J. Natl Cancer Inst.102(9), 605–613 (2010).
  • Menzies SW, Emery J, Staples M et al. Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J. Dermatol.161(6), 1270–1277 (2009).
  • Altamura D, Avramidis M, Menzies SW. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch. Dermatol.144(4), 502–506 (2008).
  • Argenziano G, Zalaudek I, Hofmann-Wellenhof R et al. Total body skin examination for skin cancer screening in patients with focused symptoms. J. Am. Acad. Dermatol. doi:10.1016/j.jaad.2010.12.0392011 (2011) (Epub ahead of print).
  • Agarwala SS, Lee SJ, Flaherty LE et al. Randomized phase III trial of high-dose interferon alfa-2b (HDI) for 4 weeks induction only in patients with intermediate- and high-risk melanoma (Intergroup trial E 1697). Presented at: American Society of Clinical Oncology Annual Meeting. Chicago, IL, USA, 3–7 June 2011. J. Clin. Oncol.29(Suppl.), (2011) (Abstract 8505).
  • Eggermont AM, Suciu S, Santinami M et al.; EORTC Melanoma Group. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised Phase III trial. Lancet372(9633), 117–126 (2008).
  • Lapouge G, Youssef KK, Vokaer B et al. Identifying the cellular origin of squamous skin tumors. Proc. Natl Acad. Sci. USA108(18), 7431–7436 (2011).
  • Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a queensland community. J. Invest. Dermatol.115(2), 273–277 (2000).
  • van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol. Biomarkers Prev.15(12), 2546–2548 (2006).
  • Hughes MC, van der Pols JC, Marks GC, Green AC et al. Food intake and risk of squamous cell carcinoma of the skin in a community: the Nambour skin cancer cohort study. Int. J. Cancer119(8), 1953–1960 (2006).
  • Butler GJ, Neale R, Green AC, Pandeya N, Whiteman DC. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. J. Am. Acad. Dermatol.53(6), 966–972 (2005).
  • Zalaudek I, Giacomel J, Schmid K. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model. J. Am. Acad. Dermatol. doi:10.1016/j.jaad.2011.02.011 (2011) (Epub ahead of print).
  • Rosendahl C, Hansen C, Cameron A et al. Measuring performance in skin cancer practice: the SCARD initiative. Int. J. Dermatol.50(1), 44–51 (2011).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.